2023-12-06 · ANDA217987
Vasopressin
vasopressin · original submission 1 · status AP.
Open full application timeline →Open selected original record →
FDA application source year
20 selected records whose approved original-submission status date falls in 2023. Dates and status codes are attributed to the retained official dataset observation.
2023-12-06 · ANDA217987
vasopressin · original submission 1 · status AP.
Open full application timeline →2023-12-05 · ANDA210317
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-11-16 · ANDA208569
teriparatide · original submission 1 · status AP.
Open full application timeline →2023-11-16 · ANDA211097
teriparatide · original submission 1 · status AP.
Open full application timeline →2023-11-16 · ANDA216075
ganirelix acetate · original submission 1 · status AP.
Open full application timeline →2023-11-08 · NDA217806
tirzepatide · original submission 1 · status AP.
Open full application timeline →2023-10-17 · NDA216834
zilucoplan sodium · original submission 1 · status AP.
Open full application timeline →2023-09-29 · NDA217569
vasopressin · original submission 1 · status AP.
Open full application timeline →2023-09-08 · NDA217159
motixafortide acetate · original submission 1 · status AP.
Open full application timeline →2023-08-14 · ANDA213521
icatibant acetate · original submission 1 · status AP.
Open full application timeline →2023-08-07 · ANDA213966
daptomycin · original submission 1 · status AP.
Open full application timeline →2023-06-22 · ANDA216839
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-06-13 · ANDA216807
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-05-26 · ANDA213206
vasopressin · original submission 1 · status AP.
Open full application timeline →2023-03-20 · ANDA216904
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2023-03-10 · NDA217026
trofinetide · original submission 1 · status AP.
Open full application timeline →2023-02-28 · ANDA215658
ganirelix acetate · original submission 1 · status AP.
Open full application timeline →2023-02-17 · NDA217171
pegcetacoplan · original submission 1 · status AP.
Open full application timeline →2023-02-07 · ANDA209611
linaclotide · original submission 1 · status AP.
Open full application timeline →2023-01-30 · NDA217415
daptomycin · original submission 1 · status AP.
Open full application timeline →